Page last updated: 2024-11-11

guajavarin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

guajavarin: from leaves of Psidium guajava [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Guajavagenus[no description available]MyrtaceaeThe myrtle plant family of the order Myrtales. It includes several aromatic medicinal plants such as EUCALYPTUS.[MeSH]
PsidiumgenusA plant genus of the family MYRTACEAE that bears an edible fruit and contains guavin B and quercetin glycosides.[MeSH]MyrtaceaeThe myrtle plant family of the order Myrtales. It includes several aromatic medicinal plants such as EUCALYPTUS.[MeSH]
Psidium guajavaspecies[no description available]MyrtaceaeThe myrtle plant family of the order Myrtales. It includes several aromatic medicinal plants such as EUCALYPTUS.[MeSH]

Cross-References

ID SourceID
PubMed CID5481224
CHEMBL ID464507
SCHEMBL ID3635416
MeSH IDM0233392

Synonyms (25)

Synonym
guaijaverin
ACON1_000559
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4s,5s)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-chromen-4-one
quercetin 3-o-.alpha.-l-arabinopyranside
4h-1-benzopyran-4-one, 3-(.alpha.-l-arabinopyranosyloxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
MEGXP0_000272
guajavarin
bdbm50248650
BRD-K73348788-001-01-6
guajaverin
CHEMBL464507 ,
SCHEMBL3635416
22255-13-6
4h-1-benzopyran-4-one, 3-(alpha-l-arabinopyranosyloxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
3-(alpha-l-arabinopyranosyloxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
quercetin-3-arabinopyranoside
DTXSID60176795
quercetin 3-o-alpha-l-arabinopyranoside, >=95% (hplc)
AKOS032948351
Q48837901
HY-N2224
CS-0019547
D85087
MS-27767
XG161780

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Pretreatment with verapamil increased the peak concentration and area under the concentration-time curve of hyperin, which were significantly higher than the control values."( Simultaneous quantification of hyperin, reynoutrin and guaijaverin in mice plasma by LC-MS/MS: application to a pharmacokinetic study.
Guo, J; Li, Z; Meng, F; Peng, S; Sun, L; Yu, L; Zhang, Y; Zhang, Z, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)0.32000.00041.877310.0000AID654333
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID1195522Inhibition of PTP1B (unknown origin) at 20 ug/ml using pNPP substrate measured after 3 mins by colorimetric assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
PTP1B inhibitors from stems of Angelica keiskei (Ashitaba).
AID395316Inhibition of Trypanosoma cruzi recombinant glycosomal GAPDH expressed in Escherichia coli by spectrophotometry2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
AID1239713Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation at 100 uM pre-incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Potential therapeutic agents for circulatory diseases from Bauhinia glauca Benth.subsp. pernervosa. (Da Ye Guan Men).
AID1194985Antioxidant activity assessed as FRAP values at 50 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID654332Inhibition of advanced glycation end-products formation after 14 days by spectrofluorimetry2012Journal of natural products, Feb-24, Volume: 75, Issue:2
Chemical constituents from the aerial parts of Aster koraiensis with protein glycation and aldose reductase inhibitory activities.
AID1194980Cytotoxicity against human HeLa cells by MTT assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1194978Cytotoxicity against human SGC7901 cells by MTT assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1194986Antioxidant activity assessed as FRAP values at 100 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1194979Cytotoxicity against human A549 cells by MTT assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1884961Prevention of Streptococcus mutans CLSM 001 adherence to sucrose-dependent glass surface at 1 to 2 mg/ml relative to control2022Journal of medicinal chemistry, 07-14, Volume: 65, Issue:13
Small Carbohydrate Derivatives as Potent Antibiofilm Agents.
AID654333Inhibition of Sprague-Dawley rat lens aldose reductase2012Journal of natural products, Feb-24, Volume: 75, Issue:2
Chemical constituents from the aerial parts of Aster koraiensis with protein glycation and aldose reductase inhibitory activities.
AID1194984Antioxidant activity assessed as FRAP values at 25 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1194982Antioxidant activity assessed as ABTS radical scavenging activity after 15 mins2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1705065Inhibition of biotinylated 5-(4-((Z)-3-Carboxy-3-hydroxyacryloyl)-4-(4-chlorobenzyl)piperidine-1-carbonyl)-2-((13,35-dioxo-39-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazole-4-yl)-3,6,9,16,19,22,25,28,31-nonaoxa-12,34-diazanonatriacontyl)oxy)benzoi2020European journal of medicinal chemistry, Dec-15, Volume: 208Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
AID1194981Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by microplate reader based assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
AID1194983Antioxidant activity assessed as FRAP values at 12.5 ug/ml incubated at 37 degC for 5 mins by FeSO4.7H2O calibration curve based method2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
Cytotoxic and antioxidant constituents from the leaves of Psidium guajava.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.76)18.2507
2000's5 (23.81)29.6817
2010's13 (61.90)24.3611
2020's2 (9.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.22 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index5.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]